Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation

Anti-Cancer Drugs

Volumn 10, Issue 2, 1999, Pages 187-193

  ElAttar, Tawfik M A ^a   Virji, Adi S ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Quercetin; Resveratrol; Squamous cell carcinoma

Indexed keywords

ANTIBIOTIC AGENT; CELL NUCLEUS DNA; QUERCETIN; RESVERATROL;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; FETAL CALF SERUM; HUMAN; HUMAN CELL; MOUTH CANCER; PRIORITY JOURNAL;

EID: 0033036639     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199902000-00007     Document Type: Article

References (47)

1. Hertog MGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 1993; 20: 21-9.
2. Das DK. Naturally occurring flavonoids: structure, chem-istry, and high performance liquid chromatography methods for separation and characterization. Methods Enzymol 1994; 234: 410-20.
3. Shahidi F, Wanasundara PK. Phenolic antioxidants. Crit Rev Food Sci Nutr 1992; 32: 67-103.
4. Wattenberg LW. Inhibition of carcinogenesis by minor anutrient constituents of the diet. Proc Nutr Soc 1990; 49: 173-83.
5. Wei H, Tye L, Bresnick E, Birt DF. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 1990; 50: 499-502.
6. Gryglewski RJ, Korbut R, Robak J, Sweis J. On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 1987; 36: 317-22.
7. Laughton MJ, Evans PJ, Moroney MA, Hoult JRS, Halliwell B. Inhibition of mammalian 5-lipooxygenase activity and cyclooxygenase by flavonoids and phenolic dietary additives - relationship to antioxidant activity and iron ion-reducing ability. Biochem Pharmacol 1991; 42: 1673-81.
8. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 1996; 50: 63- 71.
9. Frankel EN. Potential health benefits of grape and wine antioxidants. In: Stockley CS, eds. Medically, is wine just another alcoholic beverage (Proc Wolf Blass Foundation Int Wine and Health Conf) 1996: 45-9.
10. Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976; 24: 117-91.
11. Harborne JB. In: Cody V, Middleton E, Harborne JB, eds. Plant flavonoids in biology and medicine: Biochemical, pharmacological and structure-activity relationships. New York: Alan R Liss 1986: 15.
12. Ranelletti FO, Ricci R, Larocca LM, et al. Growth- inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon cancer cell lines and primary colorectal tumors. Int J Cancer 1992; 50: 486-92.
13. Scambia G, Ranelletti FO, Benedetti Panici P, et al. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast cancer cel line expressing type II estrogen-binding sites. Cancer Chemother Pharmacol 1991; 28: 255-8.
14. Albert Yeh Y, Herenyiova M, Weber G. Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells. Life Sci 1995; 57: 1285-92.
15. Scambia G, Ranelletti FO, Benedetti Panici P, et al. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II estrogen binding sitesin primary ovarian tumors and cultured cells. Br J Cancer 1990; 62: 942-7.
16. Yoshida M, Sakai T, Hosokawa N, Marui N, et al. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 1990; 260: 10-3.
17. 1 phase of the cell cycle. Cancer Res 1992; 52: 6676-81.
18. Singhal RL, Albert Yeh Y, Prajda N, Olah E, Sledge GW Jr, Weber G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 1995; 208: 425-31.
19. Greasy LL, Coffee M. Phytoalexin production potential of grape berries. J Am Soc Hortic Sci 1988; 113: 230-4.
20. Pace-Asiak CR, Hahn S, Diamandis E, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-19.
21. Goldberg DM, Soleas GJ, Hahn SE, Diamandis EP, Karumanchiri A. Identification and assay of trihydroxy-stilbenes in wine and their biological properties. In: Wakins T, ed. Wine nutritional and therapeutic benefits. Washington, DC: ACS 1996: 24-43.
22. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-4.
23. Shamon LA, Chen C, Mehta RG, Steele V, Moon RC, Pezzuto JM. A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity. Anticancer Res 1994; 14: 1775-8.
24. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-20.
25. McMurtrey KD. Resveratrol in wine. In: Watkins T, ed. Wine nutritional and therapeutic benefits. Washington, DC: ACS 1996: 44-55.
26. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981; 41: 1657-63.
27. ElAttar TMA, Lin HS. Vitamin E succinate potentiates the inhibitory effect of prostaglandins on oral squamous carcinoma cell proliferation. Prostaglandins Leukotrienes and Essential Fatty Acids 1995; 52: 69- 73.
28. Castillo MH, Perkins E, Campbel JH, et al. The effect of bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am J Surg 1989; 158: 351-5.
29. Osawa T. Phenolic antioxidants in dietary plants as antimutagens. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Washington, DC: ACS 1992; 2: 135-49.
30. Ito N, Hirose M, Shirai T. Carcinogenicity and modification of carcinogenic response by plant phenols. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Washington, DC: ACS 1992; 2: 269-83.
31. Yoshizawa S. Horiuchi T, Suganuma M, et al. Penta-O galloyl-b-D-glucose and (-)-epigallocatechin gallate: cancer preventive agents. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Washington, DC: ACS 1992; 2: 316-25.
32. Kelloff GJ, Boone CW, Steele VE, et al. Mechanistic considerations in chemopreventive drug development. J Cell Biochem Suppl 1994; 20: 1-24.
33. Stavric B. Quercetin in our diet: from potent mutagen to possible anticarcinogen. Clin Biochem 1994; 27: 245-8.
34. Cai Q, Rahn KO, Zhang R. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett 1997; 119: 99-107.
35. Hosokawa N, Hosokawa Y, Sakai T, Yoshida M. Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein in human colon cancer cells. Int J Cancer 1990; 45: 1119-24.
36. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: involvement of heart shock protein. Cancer Res 1994; 54: 4952-7.
37. Elia G, Santoro MG. Regulation of heat shock protein synthesis by quercetin in human erythroleukemia cells. Biochem J 1994; 300: 201-9.
38. Giaziani Y, Chayoth R. Regulation of cyclic AMP level and synthesis of DNA, RNA and protein by quercetin in Ehrlich ascites tumor cells. Biochem Pharmacol 1979; 28: 397-403.
39. Suolinna EM, Buchsbaum RN, Racker E. The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res 1975; 35: 1865-72.
40. Kim JH, Kim SH, Alfieri AA, Young CW. Quercetin, an inhibitor of lactase transport and a hyperthermic sensitizer of Hela cells. Cancer Res 1984; 44: 102-6.
41. End DW, Look RA, Shafer NL, Balles EA, Persico FJ. Non- selective inhibition of mammalian protein kinases by flavonoids in vitro. Res Commun Pathol Pharmacol 1987; 56: 75-86.
42. Sharma S, Stutzman JD, Kelloff GJ, Steele VE. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res 1994; 54: 5848-55.
43. Prochaska HJ, Santamaria AB. Direct measure of NADPH quinone reductase from cells cultured in microtiter wells. A screening assay for anticarcinogenic enzyme inducers. Anal Biochem 1988; 169: 328-36.
44. Gao WY, Cara A, Gallo RC, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus-type I replication. Proc Natl Acad Sci USA 1993; 90: 8925-8.
45. Lori F, Malykh A, Cara A, Sun D. Weinstein JN, Lisziewicz J, Gallo RC. Hydroxyurea as an inhibitor of human immunodeficiency virustype 1 replication. Science 1994; 266: 801-5.
46. 1-dideoxynucleoside activites against replication of human immunodeficiency virus. Proc Natl Acad Sci USA 1995; 92: 8333-7.
47. Fontecave M, Lepoivre M, Elleingand E, Gerez C. Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998; 421: 277-9.